Aktienindex
Flop-Aktien NASDAQ Biotechnology Index (NBI)
Flop-Aktien im NASDAQ Biotechnology Index (NBI)
Zeitraum
| akt. Kurs | Perf. absolut | Intraday | ||||||
|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics WKN A0MSMZ | – | – | – | 0,00 | – | |||
Apellis Pharmaceuticals WKN A2JAAW | – | – | – | 0,00 | – | |||
Apogee Therapeutics WKN A3EM1H | – | – | – | 0,00 | 7 Mrd. EUR | |||
ARCELLX WKN A3DEJC | – | – | – | 0,00 | – | |||
Atai Beckley WKN A41WEP | – | – | – | 2 Mrd. EUR | ||||
Avidity Biosciences WKN A2P5NK | – | – | – | 0,00 | – | |||
Centessa Pharmaceuticals WKN A3CQ72 | – | – | – | 5 Mrd. EUR | ||||
CRINETICS PHARMACEUTICALS WKN A2JQTJ | – | – | – | 7 Mrd. EUR | ||||
DAY ONE BIOPHARMAC.-,0001 WKN A3CQ56 | – | – | – | 0,00 | – | |||
Dynavax Technologies WKN A12EV9 | – | – | – | 0,00 | – | |||
KalVista Pharma WKN A2DG49 | – | – | – | 0,00 | 1 Mrd. EUR | |||
Nuvalent WKN A3CWDU | – | – | – | 0,00 | 7 Mrd. EUR | |||
Rapt Therapeutics WKN A418SN | – | – | – | – | ||||
Supernus Pharmaceuticals WKN A1JX3U | – | – | – | 2 Mrd. EUR | ||||
Terns Pharmaceuticals WKN A2QNWR | – | – | – | 0,00 | – | |||
Theravance Biopharma WKN A1137V | – | – | – | 5,62 | -0,11 | – | ||
Ventyx Biosciences WKN A3C53F | – | – | – | 0,00 | – | |||
Upstream Bio WKN A40QNK | 2,150 USD Nasdaq · | -22,66 % | -0,63 USD | 107 Mio. EUR | ||||
Summit Therapeutics WKN A2QDFS | 11,82 USD Nasdaq · | -16,47 % | -2,33 USD | 0,00 % | 9 Mrd. EUR | |||
NEUMORA THERAP. DL-,0001 WKN A3EVX4 | 0,370 USD Nasdaq · | -13,85 % | -0,06 USD | 63 Mio. EUR | ||||
Editas Medicine WKN A2AC4K | 1,870 USD Nasdaq · | -13,82 % | -0,30 USD | 0,00 % | 262 Mio. EUR | |||
Foghorn Therapeutics WKN A2QFQD | 1,790 USD Nasdaq · | -13,53 % | -0,28 USD | 11,50 | -0,02 | 98 Mio. EUR | ||
Cabaletta Bio WKN A2PTTB | 1,110 USD Nasdaq · | -13,28 % | -0,17 USD | 0,00 % | 218 Mio. EUR | |||
Anavex Life Sciences WKN A1411S | 0,818 USD Nasdaq · | -12,42 % | -0,12 USD | – | ||||
Absci Corp. WKN A3CVW3 | 7,475 USD Nasdaq · | -11,54 % | -0,98 USD | 1 Mrd. EUR | ||||
ARRIVENT BIOPH.INC. O.N. WKN A4016H | 11,56 USD Nasdaq · | -11,15 % | -1,45 USD | 0,00 % | 544 Mio. EUR | |||
Pyxis Oncology WKN A3C45M | 1,410 USD Nasdaq · | -10,76 % | -0,17 USD | 153 Mio. EUR | ||||
Tempus AI WKN A40EDP | 64,76 USD Nasdaq · | -9,55 % | -6,84 USD | 0,00 % | – | |||
KODIAK SCIENCES WKN A2N6P0 | 100,73 USD Nasdaq · | -9,41 % | -10,46 USD | 0,00 % | 6 Mrd. EUR | |||
ANNEXON WKN A2P859 | 3,570 USD Nasdaq · | -8,93 % | -0,35 USD | 0,00 % | 619 Mio. EUR | |||
Grail WKN A40F8M | 105,60 USD Nasdaq · | -8,88 % | -10,29 USD | 0,00 % | 4 Mrd. EUR | |||
Caris Life Sciences WKN A41A14 | 21,00 USD Nasdaq · | -8,85 % | -2,04 USD | 203,57 | 1,38 | 0,00 % | 5 Mrd. EUR | |
Recursion Pharmaceuticals WKN A3CM1C | 2,905 USD Nasdaq · | -8,79 % | -0,28 USD | 0,00 % | – | |||
KURA ONCOLOGY WKN A143UH | 7,090 USD Nasdaq · | -8,75 % | -0,68 USD | 0,00 % | 592 Mio. EUR | |||
Legend Biotech ADR WKN A2P5AH | 15,99 USD Nasdaq · | -8,63 % | -1,51 USD | 5 Mrd. EUR | ||||
Codexis WKN A0Q2S4 | 1,060 USD Nasdaq · | -8,62 % | -0,10 USD | 106 Mio. EUR | ||||
Wave Life Sciences WKN A42FEQ | 2,870 USD Nasdaq · | -8,31 % | -0,26 USD | 0,00 % | 515 Mio. EUR | |||
Beam Therapeutics WKN A2PY7P | 20,94 USD Nasdaq · | -8,28 % | -1,89 USD | 0,00 % | 2 Mrd. EUR | |||
Amylyx Pharmaceuticals WKN A3DCEY | 27,80 USD Nasdaq · | -8,22 % | -2,49 USD | 0,00 % | – | |||
ALUMIS INC. WKN A40GLK | 5,140 USD Nasdaq · | -8,21 % | -0,46 USD | 605 Mio. EUR | ||||
COMPASS Pathways WKN A2QCDR | 8,270 USD Nasdaq · | -8,21 % | -0,74 USD | 698 Mio. EUR | ||||
uniQure WKN A1XDTV | 21,88 USD Nasdaq · | -8,11 % | -1,93 USD | 0,00 % | 1 Mrd. EUR | |||
Aclaris Therapeutics WKN A1412H | 3,605 USD Nasdaq · | -8,04 % | -0,32 USD | 520 Mio. EUR | ||||
Quantum-Si A WKN A3CR9G | 1,060 USD Nasdaq · | -7,83 % | -0,09 USD | 193 Mio. EUR | ||||
ARS Pharmaceuticals WKN A2QHK9 | 3,590 USD Nasdaq · | -7,71 % | -0,30 USD | 328 Mio. EUR | ||||
4D MOLEC. THERAP. -,0001 WKN A2PS5P | 11,29 USD Nasdaq · | -7,69 % | -0,94 USD | 0,00 % | 567 Mio. EUR | |||
Invivyd WKN A3CWUU | 0,538 USD Nasdaq · | -7,63 % | -0,04 USD | – | ||||
Cullinan Therapeutics WKN A2QL3C | 9,500 USD Nasdaq · | -7,59 % | -0,78 USD | 0,00 % | – | |||
Graphite Bio WKN A407W6 | 3,820 USD Nasdaq · | -7,51 % | -0,31 USD | 0,00 % | 109 Mio. EUR | |||
Arrowhead Pharmaceuticals WKN A2AGYB | 44,21 USD Nasdaq · | -7,47 % | -3,57 USD | 0,00 % | 6 Mrd. EUR |